Lipocine Statistics
NASDAQ: LPCNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.93-0.27 (-12.27%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.86 -3.58%
Lipocine by the numbers
Lipocine has a market capitalization of $15.9 million based on 8.24M shares outstanding. With trailing EPS of $-1.85, Lipocine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.5% below its 50-day average and 55.8% below its 200-day average.
Average daily trading volume is 1.72M shares, or about $3.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LPCN valuation vs. peer median
| Metric | LPCN | Peer median | Difference |
|---|---|---|---|
| Market cap | $15.91M | $15.94M | -0% |
| Avg. volume | 1.72M | 238.63K | +622% |
Peer median across 8 companies: MRKR, PTN, RKTO, RADX, ALLR, ACTU, AEON, DARE.
Valuation
- Market cap
- $15.91M
- EPS (TTM)
- $-1.85
- Shares outstanding
- 8.24M
Price and trading
- Previous close
- 2.20
- Open
- 2.05
- Day range
- 1.89 – 2.05
- 52-week range
- 1.81 – 12.37
- 52-week change
- -38.92%
- Beta
- —
- Volume
- 2.27M
- Average volume
- 1.72M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 15.91M
- Forward Pe
- -1.56
- Eps
- -1.85
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.37
- Week52 Low
- 1.81
- Avg Volume
- 1.72M
- Shares Outstanding
- 8.24M
- Ma50
- 2.16
- Ma200
- 4.37
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -84.40%
- Pct From52w Low
- 6.63%